Understanding how well lung cancer screening works in different populations
Learning about the effectiveness of lung cancer screening in real-world target populations
This study is looking at how well lung cancer screenings work in different real-life situations, using information from various sources to find better ways to screen for lung cancer and help more people stay healthy.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11004344 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of lung cancer screening in various real-world settings, beyond the controlled environment of clinical trials. It aims to combine data from multiple sources, such as claims datasets and screening registries, to develop new methods for evaluating screening strategies. By focusing on diverse populations, the research seeks to provide insights that are more applicable to everyday clinical practice, ultimately aiming to reduce lung cancer mortality through optimized screening approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for lung cancer, particularly those from varied demographic and clinical backgrounds.
Not a fit: Patients who are not at risk for lung cancer or those who have already been diagnosed with lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved lung cancer screening strategies that save lives by detecting cancer earlier in diverse populations.
How similar studies have performed: Previous research has shown that integrating diverse data sources can enhance understanding of screening effectiveness, suggesting that this approach has potential for success.
Where this research is happening
Boston, United States
- Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Robertson, Sarah E — Harvard School of Public Health
- Study coordinator: Robertson, Sarah E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.